29 participants
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-15
- Start Date:
- 2024-09-27
- Completion:
- 2026-01-08
Conditions
- Ulcerative Colitis
Interventions
- DRUG
- BIOLOGICAL
- OTHER
No Results Yet